Health
Nepal allows late-stage trials for Chinese mRNA vaccine candidate - Xinhua
Nepal has allowed China's Walvax Biotechnology to conduct phase 3 trials for the company's mRNA COVID-19 vaccine candidate in the country, China's official Xinhua news...
